Published online Jun 28, 2014. doi: 10.4329/wjr.v6.i6.223
Revised: April 13, 2014
Accepted: May 16, 2014
Published online: June 28, 2014
Processing time: 155 Days and 15.6 Hours
The presence of white matter hyperintensities (WMHs) has been commonly associated with poor outcome in subjects with major affective disorders. Unfortunately, WMHs may be frequently confounded by the use of psychoactive medications and duration of illness. Although findings from the current literature are quite conflicting, we proposed that subjects with WMHs may be at higher suicidal risk when compared to other subgroups without. Based on the Fazekas modified scale, the severity of WMHs may serve as a trait marker of disease. Interestingly, the presence of WMHs may represent a neurobiological marker between the underlying vulnerability and clinical presentation of major affective disorders.
Core tip: Understanding neural correlates underlying psychiatric morbidity over time is critical but, to date, structural magnetic resonance imaging studies identified only not stable risk predictors of unfavourable outcome in psychiatric populations. The presence of white matter hyperintensities (WMHs) has been commonly associated with a poor outcome in individuals with major affective disorders. Based on our studies, subjects with WMHs may be considered at higher suicidal risk than those without and the severity of WMHs as assessed by the Fazekas modified scale may serve as a trait marker of disease. WMHs may represent an interesting neurobiological marker between the underlying vulnerability and clinical presentation of major affective disorders.